ArticleCurrent pharmaceutical design2024

Hua-Feng-Dan Alleviates LPS-induced Neuroinflammation by Inhibiting the TLR4/Myd88/NF-κB Pathway: Integrating Network Pharmacology and Experimental Validation.

Zehan Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.